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490Trehalose protects against spinal cord ischemia
in rabbits
Shinya Takahashi, MD, Mitsuhiro Isaka, MD, Makoto Hamaishi, MD, Katsuhiko Imai, MD,
Kazumasa Orihashi, MD, and Taijiro Sueda, MD, Hiroshima, Japan
Objective: This study tested to see if trehalose, a cytoprotective disaccharide, protects against spinal cord ischemia in
a rabbit model.
Methods: The infrarenal aorta was mobilized in four groups of 10 rabbits. In groups I, II, and III, it was clamped
proximally and distally for 20 minutes. In group I, the clamped aorta was infused at 2.5 L/min for 2 hours with lactated
Ringer’s (LR) solution. In group II, the clamped aorta was infused with 5% trehalose in LR. LR was administered
intravenously (2.0 mL/min) in groups I and II starting 30 minutes before clamping. In group III, 5% trehalose in LR was
infused intravenously only. Group IV was a sham-operated control group without aortic clamping. At 8, 24, and
48 hours after reperfusion, hind limb function was scored using the Tarlov score (paralysis [ 0, perceptible joint
movement[ 1, good joint movement but unable to stand[ 2, able to walk[ 3, normal[ 4). Histologic analysis and
electron microscopy were performed on anterior horn cells.
Results: The Tarlov scores in groups I, II, and III were, respectively, 1.16 1.4, 3.5 6 0.5, and 2.96 0.9 at 8 hours; 0.86
1.2, 3.9 6 0.3, and 2.9 6 0.9 at 24 hours; and 0.6 6 0.7, 3.9 6 0.3, and 2.7 6 0.9 at 48 hours after reperfusion. Group
IV scores were normal (46 0) at all assessments. These scores were higher in groups II and III than in group I (P < .01) at
all assessments. Scores at 24 and 48 hours were higher in group II than in group III (P < .05). In group III, delayed
paraparesis developed in one rabbit at 24 hours and in two more at 48 hours. Histopathologic analysis showed the
number of normal neurons was higher in groups II (P < .0001), III (P[ .006), and IV (P < .0001) vs group I. Electron
microscopy conﬁrmed preserved neuronal cell ultrastructure in rabbits with normal limb function.
Conclusions: Transaortic trehalose infusion was protective against paraplegia, whereas intravenous trehalose reduced
spinal cord ischemia. This study was preliminary and further studies are needed. (J Vasc Surg 2014;60:490-6.)
Clinical Relevance: Spinal cord injury after surgical repair of the thoracic or thoracoabdominal aorta is a disastrous
complication. Recently, many kinds of adjunctive therapy have been reported to be successful, including our previous
reports of cold saline and free-radical scavengers in a rabbit model of spinal cord ischemia; however, some rabbits still
became paraplegic. The total prevention of paraplegia due to spinal cord ischemia may require the development of a more
effective adjunct. Trehalose, a unique nonreducing disaccharide, stabilizes cell membranes under various stressful
conditions such as heat, freezing, osmotic shock, and dehydration. Trehalose has been used clinically as a solution for lung
preservation in transplantation. This study demonstrated the protective effect of a trehalose infusion into the clamped
segment of the aorta or transvenously to prevent spinal cord damage after spinal cord ischemia in an animal model.
Further research is needed, but the results of this study may be applicable not only to open surgery but also to thor-
acoabdominal endovascular repair.Paraplegia caused by ischemic spinal cord injury is one
of the most serious complications after open surgery and
endovascular repair of thoracoabdominal aortic aneurysms.
The incidence of paraplegia ranges from 2% to 16% in open
surgery1-4 and may be related to spinal cord malperfusion
during periods of hypotension or aortic cross-clamping.
Endovascular surgery is superior to open surgery in that
it is associated with a lower incidence of paraplegia, but it
does not eliminate the complication.5the Department of Surgery, Division of Clinical Medical Science,
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://dx.doi.org/10.1016/j.jvs.2013.06.078Adjunctive procedures for spinal cord protection have
been introduced, including cerebrospinal ﬂuid drainage,
distal perfusion of the aorta, or use of steroids and barbitu-
rates, and these have reduced the incidence of para-
plegia.3,6,7 Recently, many kinds of adjunctive therapy
have been reported8 to be successful, including our previous
reports of cold saline and free-radical scavengers in a rabbit
model of spinal cord ischemia.9,10 Despite the use of these
adjuncts, some rabbits still became paraplegic. The total
prevention of paraplegia due to spinal cord ischemia may
require the development of a more effective adjunct.
Trehalose is a unique disaccharide composed of two
glucose molecules connected through an a, a-1,1 linkage.
Recent reports have shown that trehalose protects
Drosophila and mammalian cells from anoxic stress.11 In
the clinical setting, a solution containing trehalose has
been used for lung preservation in transplantation. The
transplant was ﬂushed with the solution, and respiratory
function was preserved after an ischemic time of>4 hours.12
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to protect the spinal cord against ischemia using trehalose,
a highly soluble sugar molecule. We then investigated the
degree of protection resulting from the local or systemic
administration of trehalose in a rabbit model of spinal
cord injury.
METHODS
Animal preparation. Animal care and all procedures
were performed in compliance with the Guide for the
Care and Use of Laboratory Animals (Institute of Labora-
tory Animal Resources, Commission on Life Sciences,
National Research Council, National Academy Press,
Washington DC, revised 1996). This study protocol was
approved by the Research Facilities for Laboratory Animal
Science of the Hiroshima University School of Medicine.
Anesthesia and monitoring. Japanese White rabbits
(2.5-3.0 kg) were used in this experiment. General anes-
thesia was induced with an intramuscular injection of ket-
amine at a dose of 50 mg/kg. An ear vein catheter was
inserted for the administration of additional drugs. Cefazo-
lin (10 mg/kg) was injected through the catheter before
any surgical procedures were performed.
After a tracheostomy, the rabbits were ventilated
mechanically with a fraction of inspired oxygen of 1.0
and isoﬂurane (1.5% to 2.0%) to maintain a surgical plane
of anesthesia. Adequate ventilation was monitored by peri-
odic blood gas analysis.
A JMS C3 arterial catheter cutdown tube (JMS
Company, Hiroshima, Japan) was inserted into the right
axillary artery and the right femoral artery for blood pres-
sure monitoring and for obtaining blood samples for blood
gas analysis and blood glucose levels. A three-lead electro-
cardiogram was also monitored continuously. The rectal
temperature was continuously monitored and maintained
at 38.0 6 0.5C using a warming blanket.
Surgical procedures. With the rabbit in the right
lateral decubitus position, a ﬂank skin incision parallel to
the spine was made on the left side. The abdominal aorta
was exposed below the left renal artery and above the iliac
bifurcation retroperitoneally and encircled with sutures. A
24-gauge catheter was inserted into the aorta 2 cm above
the iliac bifurcation and connected to an extension tube.
After the intravenous administration of heparin (100 U/
kg), the abdominal aorta just distal to the left renal artery
and just proximal to the iliac bifurcation was cross-clamped
using vascular clamps. This segment, which included the
third through sixth lumber artery, was isolated for
20 minutes to produce spinal cord ischemia.
The 20-minute cross-clamp time was determined from
a series of preliminary experiments in which 15 rabbits were
divided into three groups of ﬁve rabbits each with clamping
times of 10, 15, and 20 minutes. The abdominal aorta just
distal to the left renal artery and the aortic bifurcation were
both clamped. At 2 days after reperfusion, all of the rabbits
in the group clamped for 20 minutes were paraplegic.
Drug delivery. Forty rabbits were randomly divided
into four groups (I, II, III, and IV), with 10 animals ineach group. In group I, lactated Ringer’s (LR) solution
was infused into the clamped segment of aorta at
2.5 mL/min. In group II, 5% trehalose with LR was
infused into the clamped segment of aorta, as in group I.
In groups I and II, LR was infused intravenously at
2.0 mL/min for 2 hours starting 30 minutes before clamp-
ing. In group III, 5% trehalose with LR was infused intra-
venously at 2.0 mL/min for 2 hours starting 30 minutes
before clamping, as in group I. Group IV was a sham-
operated control group without aortic clamping. The
concentration of trehalose was selected based on a previous
study that reported the optimal concentration of trehalose
for lung preservation.13 The temperature of all these
solutions was maintained at 37C by a thermostatic bath.
The catheter inserted into the clamped aortic segment
was immediately removed after the injection of the solu-
tion, and the point of catheter entry was sutured with
8-0 Prolene (Ethicon Inc, Somerville, NJ). After the aorta
was declamped, the abdomen was closed, and all catheters
were withdrawn. The animals were extubated after they
recovered from anesthesia.
Neurologic study. Each rabbit’s neurologic status was
assessed at 8, 24, and 48 hours after reperfusion by an
observer blinded to the protocol used for each animal.
The motor function of the hind limbs was graded using
the Tarlov score: 0, no movement of the hind limbs; 1,
perceptible movement of the joints of the hind limbs; 2,
good movement of the joints but an inability to stand; 3,
ability to stand and walk; and 4, complete recovery.14
Histopathologic study. Eight rabbits in each group
were euthanized after the completion of the neurologic
evaluation at 48 hours. Sectioned specimens from the
lumber spinal cord at the level of L4 to L6 that was
perfused by the clamped aorta were stained with hematox-
ylin and eosin and evaluated for ischemic pathology using
standard light microscopy. Neuronal ischemic injury was
evaluated at original magniﬁcation 200 by an observer
blinded to the treatment groups.
The number of normal motor neurons in the anterior
horn of the spinal cord (anterior to a line drawn through
the central canal perpendicular to the anterior median
ﬁssure) was counted in ﬁve slices of specimens from each
animal and was averaged. Ischemic neurons were identiﬁed
by a shrunken and triangular-shaped cell body, an eosino-
philic cytoplasm with the loss of Nissl granules, a nucleus
that was triangular and pyknotic, and ﬁnally, a smaller
neuron that underwent homogenization.
Electron microscopy. Two rabbits in each group were
anesthetized 48 hours after the experiment and transcar-
dially perfused with saline solution, quickly followed by
2% glutaraldehyde in 0.1M phosphate buffer (pH 7.6).
After perfusion, the L4 to L6 segment of the spinal cord
was removed, and slabs were placed in 2% glutaraldehyde
with phosphate-buffered saline at 4C. Slabs were washed
in phosphate buffer and incubated with 1% osmium
tetroxide (in phosphate buffer for 1 hour). Slabs were
dehydrated in a graded ethanol series. Inﬁltration was
accomplished with the use of a series of propylene oxide
Table. Proximal and distal pressure and blood glucose level during the operation
Variablea Group I Group II Group III Group IV
Arterial pressure
Proximal
Before clamp, mm Hg 108 6 13.5 112.9 6 8.0 110 6 6.2 114.0 6 10.1
During clamp, mm Hg 100 6 10.0 109.6 6 9.3 112.3 6 5.7 113.4 6 4.3
After declamp, mm Hg 89.3 6 7.1 94.4 6 8.4 106.0 6 5.3 90.4 6 12.1
Distal
Before clamp, mm Hg 98.5 6 4.3 103.8 6 10.8 97.0 6 8.7 94.4 6 4.0
During clamp, mm Hg 17.6 6 5.8 17.9 6 7.9 27.2 6 11.3 107.1 6 12.5b
After clamp, mm Hg 73.9 6 8.7 67.7 6 14.0 67.3 6 7.8 90.4 6 7.3
Blood glucose level
Before clamp, mg/dL 110.8 6 13.2 110.0 6 8.4 109.0 6 13.6 111.0 6 17.5
After clamp, mg/dL 123.0 6 8.8 125.1 6 8.3 134.8 6 25.2 104.3 6 12.4b
aData are shown as mean 6 standard deviation.
bP < .05.
Fig 1. Changes in the Tarlov score at each time point. The score
was signiﬁcantly higher in groups II and III than in group I at 8,
24, and 48 hours and was signiﬁcantly higher in group II than in
group III at 24 and 48 hours. The error bars indicate the standard
deviation.
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slabs left in 100% EmBed 812 for 6 hours. Finally, slabs
were ﬂat embedded between ACLAR sheets (Ted Pella
Inc, Redding, Calif) and dried at 60C overnight.
Slabs were glued to blank blocks, and ultrathin sections
(60-90 nm) were cut on a diamond knife, collected on
copper grids, and stained with 3% uranyl acetate in 50%
ethanol for 20 minutes, followed by lead citrate for
3 minutes. Sections were visualized and photographed on
a Hitachi H300 transmission electron microscope (Hitachi
Ltd Instruments Division, Tokyo Japan).
Statistical analysis. Results are expressed as means 6
standard deviation. Two groups were compared with
a Mann-Whitney U test. When there were more than
two groups, a one-way analysis of variance was performed,
followed by post-hoc testing with the Fisher protected least
signiﬁcant difference test to identify which group differ-
ences were signiﬁcant. Statistical signiﬁcance was assumed
at P < .05.
RESULTS
Physiologic status. No signs of toxicity were observed
after trehalose administration into the clamped aortic
segment or intravenously. The heart rate and arterial blood
gases were similar among the four groups. Data on arterial
pressure and blood glucose levels are reported in the Table.
No signiﬁcant differencewas noted in the proximal anddistal
arterial pressure among the groups during the operation. In
groups I, II, and III, blood glucose levels after aortic
declamping were higher than those before clamping (P <
.05). The increase in blood glucose levels after declamping
was not signiﬁcantly different among groups I, II, and III.
Neurologic outcome. The neurologic results are
summarized in Fig 1. The Tarlov scores in groups I, II,
III, and IV were, respectively: 1.1 6 1.4, 3.5 6 0.5, 2.9 6
0.9 and 4.06 0 at 8 hours; 0.86 1.2, 3.96 0.3, 2.96 0.9
and 4.0 6 0 at 24 hours; and 0.6 6 0.7, 3.9 6 0.3, 2.7 6
0.9 and 4.06 0 at 48 hours after reperfusion. The scores at
all time points postoperatively were signiﬁcantly higher in
groups II and III than in group I (P < .01). The scores at24 and 48 hours after reperfusion were signiﬁcantly higher
in group II than in group III (P < .05). Delayed para-
paresis was observed in group I in one rabbit at 48 hours
and in group III in one rabbit at 24 hours and in two
rabbits at 48 hours.
Histopathologic assessment. Fig 2 shows the typical
histopathologic ﬁndings of the spinal cord from a group I
rabbit with paraplegia, a group II rabbit with normal
neurologic function, a group III rabbit with Tarlov 2
paraparesis, and a group IV rabbit with normal neurologic
function. Necrosis in the anterior horn was detected in
group I (Fig 2, A), and the motor neurons were disrupted,
with evidence of vacuolation in the cytoplasm and loss of
Nissl granules. Inﬂammatory cell accumulation was detec-
ted. In group II (Fig 2, B), the motor neurons had
a normal appearance and minimal inﬂammatory cell accu-
mulation was detected. Normal and necrotic motor
neurons were both present in group III (Fig 2, C). In
group IV (Fig 2, D), all of the motor neuron cells had
a normal appearance, without inﬂammatory changes.
The number of normal motor neurons in the anterior
horn of the spinal cord was 5.8 6 2.2, 48.3 6 4.9,
Fig 2. Typical histopathologic ﬁndings in the spinal cord 48 hours after reperfusion (hematoxylin and eosin stain;
original magniﬁcation 200). A, In group I, w90% of motor neurons were lost. B, In group II, no ischemic damage
was detected, and there were many motor neurons. C, In group III, there were intact neurons, but w70% of motor
neurons were lost. D, The spinal cord from a sham-operated control rabbit was intact. The arrows indicate normal
motor neurons, and the arrowheads, necrotic neurons.
Fig 3. The number of normal neurons was signiﬁcantly larger in
groups II and III than in group I. Moreover, the number of
normal neurons was signiﬁcantly higher in group II than in group
III. The number of normal neurons was signiﬁcantly larger in
group IV than groups I, II, and III (P < .0001). The error bars
indicate the standard deviation.
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groups I, II, III, and IV, respectively. The number of
normal neurons was signiﬁcantly higher in groups II and
IV than in group I (P < .0001). Moreover, the number
of normal neurons in group III was signiﬁcantly higher
than that in group I (P ¼ .006; Fig 3).
Electron microscopy. In groups I, II, and III, rabbits
with paraplegia or paraparesis, or both, and rabbits with
normal limb function were selected and their spinal cord
specimens were examined by electron microscopy. In
group IV, two rabbits with normal limb function were
examined. Fig 4 shows the typical transmission electron
microscopic ﬁndings of neuronal cells in the anterior horn
of the spinal cord from a rabbit in group I with paraplegia,
a group II rabbit with normal neurologic function, a group
III rabbit with Tarlov 2 paraparesis, and a group IV rabbit
with normal neurologic function.
In group I, parts of the neuronal cell membranes were
fragmented, and cytoplasmic elements were sparse. The
mitochondria of neuronal cells showed swelling and disrup-
tion as well. All of these ﬁndings indicated necrosis (Fig. 4,
A and B). Cell membranes in group II showed normal
structure and the cytoplasmic components were intact
(Fig 4, C and D). In group III, there were ﬁndings that
were similar to those in groups I and II (Fig 4, E). Cell
membranes in group IV showed normal structure, and
the cytoplasmic components were intact (Fig. 4, F). There
was no indication of apoptosis in any of the groups.DISCUSSION
This study demonstrates that a normothermic trehalose
solution infused into an isolated aortic segment as well as
intravenously can reduce the neurologic damage caused
by spinal cord ischemia in a rabbit model.
Fig 4. Typical transmission electron microscopic ﬁndings in neuronal cells from the anterior horn of the spinal cord. In
group I, (A) necrosis of nucleus and (B) disruption of the cell membrane (arrow). In group II, (C) normal nucleus and
cytoplasm and (D) normal cell membrane protecting cytoplasmic components. E, In group III, normal nucleus (arrow)
and ischemic nucleus with chromatin condensation (arrowhead). F, In group IV, normal neuron cell. Images are at
original magniﬁcation 3000 (A, C, E, and F), 10,000 (D), and 15,000 (B).
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is a nonreducing disaccharide and can be converted into
glucose by hydrolysis. Trehalose is detected in abundance
in many prokaryotes, fungi, yeasts, some desert plants, and
the body ﬂuid of insects.15 Several studies have reported
that trehalose has a preserving and stabilizing effect on cell
membranes under severe conditions such as high tempera-
ture, freezing, osmotic shock, and dehydration.16,17 In other
studies, trehalose has been proven to be an effective
compound to prevent protein aggregation in Alzheimer’s
disease, Huntington’s disease, and prion disease in vitro.18
The effect of trehalose in preventing ischemia or an
anoxic state has been described, but there is a paucity of
data. Chen et al11,19 reported that human HEK-293 cells
transfected with the gene that synthesizes trehalose accu-
mulated intracellular trehalose during hypoxia. They also
reported that trehalose protects Drosophila and mammalian
cells from anoxic stress. After exposure to low oxygen, the
amount of ubiquitinated protein of human HEK-293 cells
transfected with the trehalose gene is less than that of
human HEK-293 cells without trehalose gene transfection.
In an experimental lung transplantation model, a lung
preservation solution containing trehalose (ET-Kyoto solu-
tion) allowed longer lung preservation compared with other
solutions that lacked trehalose.20 In the clinical setting, theischemic time of a donor lung preserved by ET-Kyoto solu-
tion was about 10 hours, and the partial pressure of arterial
oxygen (fraction of inspired oxygen ¼ 1.0) was maintained
>400 mm Hg postoperatively, without the patient devel-
oping any signiﬁcant complications.21
Saccharides are considered to play a role as osmotic
impermeants and serve as an energy source for the organs
during ischemia.22 Disaccharides (trehalose, maltose,
sucrose) and trisaccharides (rafﬁnose, melezitose) are supe-
rior to monosaccharides (glucose, fructose), which pene-
trate the cell membrane relatively easily and are commonly
used as osmotic agents to suppress the edema during organ
preservation. Among the disaccharides, trehalose was supe-
rior to maltose for lung preservation, which may reﬂect
that the reducing sugar maltose destabilizes the membrane
by reacting with membrane proteins.23 Given this evidence,
we hypothesized that trehalose may be effective to protect
the spinal cord from ischemic injury during thoracic and
thoracoabdominal aortic surgery.
Before this study was started, the concentration of
trehalose solution and the administration route were
selected based on previous studies that used ET-Kyoto
solution for lung preservation. Hirata et al13 reported
that 3.5% and 7.0% trehalose solutions both maintained
acute canine lung function and protected endothelial cells
JOURNAL OF VASCULAR SURGERY
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preservation of lung oxygenation capacity when lungs were
stored for 20 hours at 4C before transplantation. Bando
et al24 reported that an extracellular solution with 4.1%
trehalose achieved high lung oxygenation capacity and
low pulmonary artery pressure and maintained normal
cell structure in an extracorporeal rat lung perfusion model.
In contrast to these two ex vivo studies in which treha-
lose solution was directly perfused into the pulmonary
artery, our study was in vivo, and the trehalose solution
was directly injected into the clamped segment of aorta
to deliver the sugar solution to motor neurons. However,
transaortic infusion is impossible in the case of endovascu-
lar repair, and intravenous infusion will be necessary in the
clinical setting. In the present study, hind limb function
was preserved in all of the rabbits with transaortic infusion
and was preserved after intravenous infusion in four rabbits
(40%), but paraparesis occurred in six (60%). Microscopic
results showed that the transaortic injection group had
less motor neuron injury than the sham-operated control
group (49.0 vs 63.9), whereas the intravenous infusion
group showed signiﬁcant motor neuron loss compared
with the sham-operated control group (16.0 vs 63.9).
The number of intact motor neurons was signiﬁcantly
larger in the transaortic group than in the intravenous
group. The number of intact motor neurons in the intrave-
nous group was signiﬁcantly higher than in group I (16.0
vs 5.8), where only LR was injected into the clamped
segment of aorta. These results indicate that a transaortic
trehalose infusion is superior to intravenous infusion but
that an intravenous infusion has some potential to prevent
spinal cord injury.
Previous studies have shown that neuronal injury
caused by spinal cord ischemia occurs in two phases, an
immediate phase and a delayed phase.25,26 Disruption of
infrarenal abdominal aortic blood ﬂow in those studies
for 15 minutes caused immediate neuronal injury that
was evident after 24 to 48 hours and delayed paraplegia
that became evident at 24 hours to 7 days. Immediate
injury is often caused by a severe ischemic insult that results
in rapid necrosis of neuronal cells. Delayed injury is caused
by apoptosis or necrosis. In the present study, two rabbits
in group III could stand and walk after the operation, but
there was delayed paraparesis at 48 hours.
Several studies have investigated the mechanism of
cytoprotection by trehalose.27 Trehalose prevents fusion
of the lipid bilayer and leakage of cellular contents by
binding to the phospholipids in the lipid bilayer of the cell
membrane, thereby stabilizing the structure. Moreover,
trehalose concentrates surrounding water molecules close
to the cell membrane and preserves its native properties.
Although proving this mechanism is difﬁcult, Fukuse
et al20 used an ex vivo rat lung model that was reperfused
after 14 hours and found mitochondrial changes and
swelling on electron microscopy that did not occur when
lungs were perfused with a solution containing trehalose
before ischemia. These results support the concept that
trehalose has a protective effect on vascular endothelial cells.Electron microscopic examination in the present study
revealed swelling and disruption of the mitochondria and
alterations of cell membranes of motor neurons in the
control group. However, several motor neurons in group
II showed preserved cellular membranes and intracellular
structures with minimal changes. These differences may
result from the intensity of the lipid bilayer, with or without
trehalose, and imply trehalose protects structures of the cell
membrane, mitochondria, and other components.
Clinically, spinal cord ischemia often occurs with
clamp/coverage of the T8 to L2 segment, and supraceliac
and thoracic aortic clamping in rabbits is ideal for modeling
the clinical problem. However, approaching the suprarenal
aorta is technically difﬁcult, and rabbits have poor survival
after opening the thoracic cavity. The main source of blood
ﬂow to the rabbit spinal cord is a segmental supply from the
abdominal aorta.28 Our model of spinal cord ischemia was
very reproducible.
We determined the effect of trehalose on blood pres-
sure and blood glucose levels to determine if changes in
these parameters might affect spinal cord injury. The time
course of blood pressure in the trehalose-administrated
group was similar to that in the control group. No hemo-
dynamic effects of trehalose were observed. Blood
glucose levels after declamping slightly increased compared
with baseline; however, trehalose had no effect on this
change.
Several studies have focused on the toxicity associated
with trehalose; however, no adverse effects were observed
in any of the studies despite the high concentration of
trehalose (10%) given intravenously.29,30 In rabbits and
humans, intravenous trehalose is relatively quickly removed
from the plasma by renal and other tissue-speciﬁc trehalase
activity, and there is little accumulation of this sugar.29,31
This study has some limitations. First, the concentra-
tion of trehalose solution was selected based on a literature
review, and the most appropriate concentration and dosing
period were not examined. Further investigation to
improve the efﬁcacy of trehalose infusion will be necessary.
Second, how trehalose injected into the aorta was deliv-
ered to the spinal cord is not clear, and this will also be difﬁ-
cult to determine in the clinical setting. However,
multidetector computed tomography has recently shown
an arterial communication between the intercostal and
lumber arteries and the anterior spinal cord artery, the artery
of Adamkiewicz, which supplies blood ﬂow to the spinal
cord.32 In the clinical setting, direct infusion of trehalose
solution into the artery of Adamkiewicz may be possible
during open surgery via a catheter in an intercostal artery.
Third, although the mechanism of trehalose in spinal
cord protection is not clear, our study shows that the
protective effect of trehalose against spinal cord ischemia
is partly related to the preservation of cell membranes,
mitochondria, and other cytoplasmic structures.
Fourth, we investigated only the early phase of spinal
cord ischemia. In the future, it will be necessary to examine
the protective effect of trehalose in the delayed phase and
to compare trehalose with other saccharides.
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Transaortic trehalose infusion was protective against
paraplegia, whereas intravenous trehalose reduced spinal
cord ischemia in a rabbit model. This study indicated that
this method can potentially be a useful adjunct for spinal
cord protection during thoracic and thoracoabdominal
aortic operations.
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